Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $26.44, demonstrating a -2.4% change from the preceding ...

Shareholders of Hims & Hers Health would probably like to forget the past six months even happened. The stock dropped 57.1% ...

Hims & Hers is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personalized treatments. Learn more.

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 2.2% in the morning session after Morgan Stanley reiterated ...

Hims & Hers Health shows 50% revenue growth, $1B in cash, and 2.4x 2026 sales with strong personalization and GLP-1 sales.

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $28.89, denoting a -5.19% move from the ...

What the recent share performance signals for Hims & Hers Health (HIMS) Hims & Hers Health (HIMS) has drawn investor ...

Financial giants have made a conspicuous bullish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health (NYSE:HIMS) revealed 13 unusual trades. Delving into the details, we ...

Hims & Hers Health (NYSE:HIMS) is launching a Super Bowl campaign titled "Rich People Live Longer" to highlight healthcare inequality. The campaign uses one of the highest profile US advertising slots ...